Because performance of screening for colorectal cancer among patients aged 50-75 is now a standard measure in many healthcare systems, it is likely that similar patterns of underuse and overuse can be found in other high performing healthcare systems.
Although Ponti and Ponz de Leon [1] suggested the necessity of surveillance for MTS gene carriers and symptomatic patients with MTS, the effectiveness of such surveillance has been controversial because of the difficulty of screening for various kinds of malignancies.
This is good news because no other method of screening for lung cancer has ever reduced deaths from the disease.
In the current study the most commonly cited reason (43.6%) for testing was "I had sex without a condom", with smaller proportions of youth stating that they had been tested because it was part of screening for sexually transmitted diseases (20.4%) or it had been recommended by a health professional (16.6%).
"I've got to give credit to them because they did a terrific job of screening for me and John did a great job of finding me".
There might be controversy surrounding the routine use of screening for depression because of the potential that women "at risk of developing PPD" might not fall under the category.
Although it was not a trial of screening, its results have convinced many practitioners to adopt some type of screening for GDM because logically, in order to treat GDM (an asymptomatic entity), one must first screen for it.
Because of the widely recognized benefits of screening for cervical cancer, there is considerable enthusiasm for anal cancer screening in high-risk populations such as HIV-infected MSM, however, little is known about current implementation of such screening practices across jurisdictions.
This is because of concerns about the challenges of screening for this complex condition, including the need for genetic counselling and education and the potential psychosocial and other impacts of a positive result, discussed further in Finucane et al. 4 FXS is the most commonly inherited cause of intellectual and developmental disability.
Because of the lack of a systematic, organized screening for colo-rectal cancer in Luxembourg, the data presented here may help to define new preventive screening approaches, to increase funding and hasten the introduction of screening for this tumour.
